At HIMSS, Google Cloud announced new AI features designed to assist providers, payers and any other healthcare organizations seeking to make better use of their clinical data.
Join MedCity News and nearly 300 healthcare investors, startups, and innovative-minded executives in Chicago at the Ritz Carlton on May 21-22. Space is limited. Secure your spot today to attend!
With pimavanserin's Phase 3 failure in schizophrenia, Acadia Pharmaceuticals said it will no longer run clinical trials for the drug, whose lone approval is for treating psychosis from Parkinson's disease. The FDA previously rebuffed regulatory submissions for the drug in dementia and Alzheimer's disease.
Episode 2 of our Debunked show is now available. Editor-in-Chief Arundhati Parmar and co-host Samir Batra discuss unfair hospital pricing and what CA is trying to do starting April 1 to prevent too many large healthcare transactions involving CA healthcare entities that they could deem anticompetitive in nature.
Post Comment
No comments